Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia

التفاصيل البيبلوغرافية
العنوان: Diagnostic testing and antibiotic utilization among inpatients evaluated for coronavirus disease 2019 (COVID-19) pneumonia
المؤلفون: Wimmer, Megan R., Griffin, Meggie, Peterson-Weber, Alex, Schulz, Lucas T., Hamel, Ashlee G., Schwei, Rebecca J., Fong, Karen, Burgess, Donna R., Brett, Meghan, Hale, Cory M., Holubar, Marisa, Jain, Rupali, Larry, Rachel, Spivak, Emily S., Newland, Helen, Njoku, Jessica, Postelnick, Michael, Walraven, Carla, Pulia, Michael S.
المصدر: Infection Control & Hospital Epidemiology; May 2024, Vol. 45 Issue: 5 p667-669, 3p
مستخلص: AbstractWe evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2–positive patients and even higher among those who underwent procalcitonin testing (68%).
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0899823X
15596834
DOI:10.1017/ice.2023.272